Cambridge Investment Research Advisors Inc. Has $58.49 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Cambridge Investment Research Advisors Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.8% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 115,631 shares of the healthcare conglomerate's stock after selling 5,885 shares during the period. Cambridge Investment Research Advisors Inc.'s holdings in UnitedHealth Group were worth $58,493,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in the business. Western Pacific Wealth Management LP lifted its stake in shares of UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock valued at $456,000 after acquiring an additional 19 shares during the last quarter. MCF Advisors LLC increased its holdings in UnitedHealth Group by 0.8% in the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after purchasing an additional 20 shares in the last quarter. Axiom Financial Strategies LLC grew its holdings in UnitedHealth Group by 3.6% in the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after purchasing an additional 20 shares during the period. Richwood Investment Advisors LLC boosted its holdings in UnitedHealth Group by 0.4% in the fourth quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after acquiring an additional 20 shares in the last quarter. Finally, 44 Wealth Management LLC grew its position in UnitedHealth Group by 1.6% in the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock valued at $662,000 after purchasing an additional 21 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.9 %

UNH stock traded down $3.46 during mid-day trading on Wednesday, reaching $391.05. 8,514,401 shares of the stock traded hands, compared to its average volume of 4,667,655. The stock's fifty day moving average is $491.52 and its 200-day moving average is $525.18. The company has a market cap of $355.95 billion, a P/E ratio of 25.23, a P/E/G ratio of 1.37 and a beta of 0.56. UnitedHealth Group Incorporated has a 52-week low of $385.70 and a 52-week high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the firm earned $6.91 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.15%. UnitedHealth Group's payout ratio is presently 35.18%.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. HSBC reissued a "hold" rating and set a $490.00 target price on shares of UnitedHealth Group in a research report on Tuesday, April 22nd. KeyCorp dropped their price objective on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research report on Tuesday, January 28th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Finally, Oppenheimer lowered their target price on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research note on Monday, April 21st. Four equities research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $596.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.